Iisrael - heebrea - Ministry of Health

dexcel ltd, israel - propranolol hydrochloride - טבליה - propranolol hydrochloride 10 mg - propranolol - propranolol - management of angina pectoris, control of essential and renal hypertension, control of essential tremor, control of most forms of cardiac dysrhythmias, adjunct in the management of tachycardias and arrhythmias due to thyrotoxicosis and thyrotoxic crises, management of hypertrophic obstructive cardiomyopathy, management of pheochromocytoma (with an alpha blocker). prolol is also indicated for the long term prophylaxis after recovery from acute myocardial infarction (treatment to be initiated by a hospital physician), migrane prophylaxis.

Iisrael - heebrea - Ministry of Health

abic ltd. - propranolol hydrochloride - טבליה - propranolol hydrochloride 40 mg - propranolol - propranolol - 1. management of angina pectoris. 2. control of essential and renal hypertension essential tremor most forms of cardiac dysrhythmias. 3. as and adjunct in the management of tachycardias and arrhythmias due to thyrotoxicosis and thyrotoxic crises hypertrophic obstructive cardiomyopathy pheochromocytoma (with an alpha blocker). 4. deralin is also indicated for long term prophylaxis following recovery from acute myocardial infarction (treatment to be initiated by a hospital physician) . 5. migraine prophylaxis.

Iisrael - heebrea - Ministry of Health

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - ventri is primarily intended for cardiac applications but also supports non-cardiac procedures of the patient’s head, chest and body extremities.

Iisrael - heebrea - Ministry of Health

astrazeneca (israel) ltd - ticagrelor - טבליות מצופות פילם - ticagrelor 90 mg - ticagrelor - ticagrelor - brilinta, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (unstable angina, non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]); including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

Iisrael - heebrea - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Iisrael - heebrea - Ministry of Health

eli lilly israel ltd - prasugrel as hydrochloride - טבליות מצופות פילם - prasugrel as hydrochloride 5 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci).the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 and a weight below 60 kg3.

Iisrael - heebrea - Ministry of Health

eli lilly israel ltd - prasugrel as hydrochloride - טבליות מצופות פילם - prasugrel as hydrochloride 10 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci). the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 and a weight below 60 kg3.

Iisrael - heebrea - Ministry of Health

mckesson israel ltd. - אחר - software system for cardiac image and information management

Iisrael - heebrea - Ministry of Health

spectrum dynamics (israel) ltd. - רופא - the d-spect™ cardiac scanner is an emission computed tomography system intended to detect the location and distribution of gamma ray radionuclides in the body and produce cross-sectional images through computer reconstruction of the data.

Iisrael - heebrea - Ministry of Health

ג'י אי מדיקל סיסטמס ישראל - צוות טכני - system is to perform nuclear imaging procedures for detection and imaging of radioisotope tracer uptake in the patient body for clinical diagnostic purposes. discovery nm 530c is primarily intended for cardiac applications.